Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery

PURPOSE: To analyze the outcomes of chemoradiotherapy for extrahepatic bile duct (EHBD) cancer patients who underwent R2 resection or bypass surgery and to identify prognostic factors affecting clinical outcomes, especially in terms of molecular biomarkers. MATERIALS AND METHODS: Medical records of...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Hyeon Kang, Park, Hae Jin, Kim, Kyubo, Chie, Eui Kyu, Min, Hye Sook, Ha, Sung W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546288/
https://www.ncbi.nlm.nih.gov/pubmed/23346539
http://dx.doi.org/10.3857/roj.2012.30.4.197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546288/
https://www.ncbi.nlm.nih.gov/pubmed/23346539
http://dx.doi.org/10.3857/roj.2012.30.4.197

Ejemplares similares